Skip to main content

NxNeuro

This company develops and provides diagnostic and therapeutic technologies for refractory epilepsy. Their patented technology aims to offer effective treatment options for patients who have not responded to other therapies.

Traction –/10
Nîmes, France · HQ
5300+ followers
  • Biotechnology
  • Healthcare Technology
Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Abed Hammoud

Founder / CEO / CTO

Product

Features

  • This company develops and provides diagnostic and therapeutic technologies for refractory epilepsy. Their patented technology aims to offer effective treatment options for patients who have not responded to other therapies.
This profile is AI-generated and may contain inaccuracies.